FIELD: medicine.
SUBSTANCE: method involves recording dynamic changes of forecasting-significant hepatic failure-specific indices on the background of hepatic failure intensive care before and after intravenous infusion of salt solution through fetal liver suspension. The clinical indices like encephalopathy, jaundice, ascitic hydrops fetalis, coagulopathy and laboratory indices like bilirubin factor increase, albumin and prothrombin factor reduction belong to the indices. Positive dynamic changes of these values being observed, fetal tissue transplantation is considered to be efficient, negative dynamic changes being observed, the transplantation is considered to be inefficient.
EFFECT: high accuracy and accelerated treatment prognosis.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF NON-INVASIVE DIAGNOSTICS OF FIBROSIS IN CASE OF DIFFUSE LIVERE DISEASES | 2010 |
|
RU2422091C1 |
| BIOTRANSPLANT, TREATMENT METHOD OF CHRONIC LIVER DISEASES AND TREATMENT METHOD OF LIVER CIRRHOSIS AND PORTAL HYPERTENSION | 2007 |
|
RU2368384C2 |
| METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 |
|
RU2813033C1 |
| METHOD FOR PREDICTION OF FATAL OUTCOMES IN PATIENTS SUFFERING VIRAL OR ALCOHOLIC CIRRHOSIS | 2011 |
|
RU2465818C1 |
| METHOD OF ESTIMATING RISK OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT SURGERY IN PATIENTS WITH PORTAL HYPERTENSION OF CIRRHOTIC GENESIS | 2011 |
|
RU2492479C2 |
| METHOD FOR TREATING THE CASES OF CHRONIC DIFFUSE HEPATIC DISEASES | 2004 |
|
RU2283113C2 |
| METHOD FOR PREDICTING AND DIAGNOSTIC EVALUATION OF DEGREE OF COMPENSATION OF CHRONIC LIVER IMPAIRMENT AND SEVERITY OF CLINICAL COURSE OF LIVER CIRRHOSIS | 2007 |
|
RU2363389C1 |
| METHOD FOR TREATING CHRONIC DIFFUSE LIVER DISEASES | 1998 |
|
RU2161036C2 |
| METHOD FOR QUANTITATIVE ESTIMATION OF SEVERITY OF ALCOHOLIC CIRRHOSIS AND PREDICTION OF FATALITY DURING CURRENT HOSPITALISATION | 2020 |
|
RU2747771C1 |
| METHOD OF PREDICTING DEVELOPMENT OF CRITICAL HEPATIC FAILURE BASING ON SELENIUM LEVEL IN SERUM | 2014 |
|
RU2549963C1 |
